Skip to content

Preoperative Survey to Evaluate Patient Allergy

Preoperative Survey to Evaluate Patient Allergy List, Type of Response to Listed Medication, and Its Relevance to Perioperative Care

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05670756
Enrollment
250
Registered
2023-01-04
Start date
2023-05-01
Completion date
2023-11-13
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Reaction, Allergy Drug, Pediatric, Surgery

Brief summary

The study will only involve identification of the listed allergies from the electronic medical record and investigation into the symptoms that prompted this allergy listing. The purpose is to evaluate demographics and prevalence of allergies in patients presenting for surgery, evaluate the medical decision making process behind allergy identification, and determine its potential impact on perioperative care. The participants will be asked to complete a survey in REDCap using an iPad during the visit.

Interventions

OTHERSurvey

Parents/guardians will complete a survey about when the medication allergy was identified and the exact symptomatology that resulted in determination of the allergy.

Sponsors

Nationwide Children's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 21 Years
Healthy volunteers
No

Inclusion criteria

* Patients 0-21 years of age presenting for surgery or procedure requiring anesthesia

Exclusion criteria

* Patients who are not able cognitively to complete the computerized survey due to physical or intellectual impairment or communication issues related to non-English speaking patients

Design outcomes

Primary

MeasureTime frameDescription
True Allergy (Consistent With an IgE-mediated Reaction)BaselineCutaneous reactions (hives, urticarial, skin redness, rash) within 6 h of the dose or Anaphylaxis or anaphylactoid reaction within 6 h of the dose

Secondary

MeasureTime frameDescription
Unlikely True Allergy (Less Relevant With an IgE-mediated Reaction)BaselineCutaneous reactions (rash, skin redness) longer than 6 h after the dose
Not True Allergy (Not Related to IgE-mediated Reaction)BaselineAllergy listed in the medical record but instead: Recognized adverse effect of the medication, Family history of allergy, Based on medical history or other reasons, or Parents reported their child has no allergy

Countries

United States

Participant flow

Participants by arm

ArmCount
Medication Allergy
Patients who have a medication allergy listed in their electronic medical record. Survey: Parents/guardians will complete a survey about when the medication allergy was identified and the exact symptomatology that resulted in determination of the allergy.
250
Total250

Baseline characteristics

CharacteristicMedication Allergy
Age, Categorical
<=18 years
250 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous9 years
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
244 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
3 Participants
Race (NIH/OMB)
Black or African American
18 Participants
Race (NIH/OMB)
More than one race
9 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
219 Participants
Region of Enrollment
United States
250 participants
Sex: Female, Male
Female
132 Participants
Sex: Female, Male
Male
118 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 250
other
Total, other adverse events
0 / 250
serious
Total, serious adverse events
0 / 250

Outcome results

Primary

True Allergy (Consistent With an IgE-mediated Reaction)

Cutaneous reactions (hives, urticarial, skin redness, rash) within 6 h of the dose or Anaphylaxis or anaphylactoid reaction within 6 h of the dose

Time frame: Baseline

Population: In the 250 participants, there were at total of 301 medication allergies reported due to some participants being allergic to multiple medications.

ArmMeasureValue (NUMBER)
Medication AllergiesTrue Allergy (Consistent With an IgE-mediated Reaction)135 Allergies
Secondary

Not True Allergy (Not Related to IgE-mediated Reaction)

Allergy listed in the medical record but instead: Recognized adverse effect of the medication, Family history of allergy, Based on medical history or other reasons, or Parents reported their child has no allergy

Time frame: Baseline

Population: In the 250 participants, there were at total of 301 medication allergies reported due to some participants being allergic to multiple medications.

ArmMeasureValue (NUMBER)
Medication AllergiesNot True Allergy (Not Related to IgE-mediated Reaction)93 Allergies
Secondary

Unlikely True Allergy (Less Relevant With an IgE-mediated Reaction)

Cutaneous reactions (rash, skin redness) longer than 6 h after the dose

Time frame: Baseline

Population: In the 250 participants, there were at total of 301 medication allergies reported due to some participants being allergic to multiple medications.

ArmMeasureValue (NUMBER)
Medication AllergiesUnlikely True Allergy (Less Relevant With an IgE-mediated Reaction)73 Allergies

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026